|
Control of CMV infection post-HCT using attenuated MVA-based CMV subunit vaccine
|
5R01CA077544-16
|
$539,228
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection
|
5R01CA181045-04
|
$710,976
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
City of Hope Lymphoma SPORE
|
3P50CA107399-10S1
|
$300,000
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia
|
5R01CA195519-02
|
$272,213
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Optimizing Busulfan: Efficacy Toxicity and Pharmacometabolomics
|
5R01CA182963-05
|
$515,038
|
MCCUNE, JEANNINE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient
|
5U01CA183012-04
|
$312,304
|
ZAIA, JOHN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT
|
5R01CA183605-05
|
$894,037
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Novel Role(s) of Nrf2 in the Growth of Post-Transplantation Cancer
|
5R01CA193675-02
|
$411,185
|
PAL, SOUMITRO
|
BOSTON CHILDREN'S HOSPITAL
|
|
SPORE in Myeloid Malignancies
|
1P50CA206963-01A1
|
$2,185,000
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Development of Novel Therapeutic Strategies in Human Leukemias
|
5P01CA066996-19
|
$2,248,452
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Statin Intervention to Slow the Time to Hepatocellular Carcinoma Recurrence in Cirrhotics Awaiting Liver Transplantation
|
1R01CA218486-01
|
$697,142
|
HUSSAIN, SHEHNAZ
|
CEDARS-SINAI MEDICAL CENTER
|
|
Bone Deficits and Excess Adiposity after Pediatric Bone Marrow Transplantation
|
5K07CA166177-05
|
$164,862
|
MOSTOUFI-MOAB, SOGOL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
KIR-FAVORABLE HAPLOIDENTICAL TRANSPLANTATION IN CHILDREN
|
5R01CA181050-04
|
$90,772
|
PULSIPHER, MICHAEL
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Nonadherence: Undermining health outcomes in pediatric HSCT?
|
5R01CA157460-06
|
$269,433
|
PAI, AHNA
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeting Cdc42 for bone marrow transplant therapies
|
5R01CA193350-03
|
$356,850
|
ZHENG, YI
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S2
|
$60,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S3
|
$100,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
|
5P01CA142106-13
|
$1,630,446
|
CUTLER, COREY
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
2P30CA006516-52
|
$11,592,798
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S1
|
$112,500
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Integrative Oncogenomics of Multiple Myeloma
|
2P01CA155258-06
|
$2,086,676
|
MUNSHI, NIKHIL
|
DANA-FARBER CANCER INST
|
|
Reconstitution of Regulatory T Cells After Stem Cell Transplantation
|
5R01CA183560-05
|
$500,000
|
RITZ, JEROME
|
DANA-FARBER CANCER INST
|
|
Manipulation of Immune Responsiveness after Hematopoietic Cell Transplantation
|
5R01CA183559-05
|
$700,000
|
SOIFFER, ROBERT
|
DANA-FARBER CANCER INST
|
|
Patient-centered home-based hematopoietic stem cell transplantation
|
5R01CA203950-02
|
$645,651
|
CHAO, NELSON
|
DUKE UNIVERSITY
|
|
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
|
5K08CA184552-04
|
$127,865
|
DOAN, PHUONG
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-43S1
|
$116,657
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-43S2
|
$29,688
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-43S3
|
$83,246
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA014236-43
|
$5,679,062
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Dissecting mechanism(s) by which ionizing radiation promotes clonal expansion of premalignant cells in the thymus
|
5K99CA212198-02
|
$116,127
|
LEE, CHANG LUNG
|
DUKE UNIVERSITY
|
|
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant
|
5R01CA136934-09
|
$357,750
|
YANG, YIPING
|
DUKE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S1
|
$59,999
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S2
|
$102,081
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Using donor pDC to optimize GvHD and GvL in allogeneic stem cell transplantation
|
5R01CA188523-04
|
$323,700
|
WALLER, EDMUND
|
EMORY UNIVERSITY
|
|
Pediatric Oncology Research Training Program
|
2T32CA009351-39
|
$272,307
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-17
|
$701,719
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W
|
5K08CA169485-05
|
$171,372
|
CHAPUIS, AUDE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Investigating the role of interleukin-22 in thymus function
|
5R00CA176376-03
|
$247,118
|
DUDAKOV, JARROD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S1
|
$249,999
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S2
|
$125,000
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S3
|
$58,085
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S4
|
$70,220
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
5P30CA015704-42
|
$9,559,285
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Improving Outcomes Assessment in Chronic Graft versus Host Disease
|
5R01CA118953-10
|
$812,043
|
LEE, STEPHANIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
|
3R01CA054498-25S1
|
$44,259
|
LEISENRING, WENDY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted Alpha Radioimmunotherapy with Haploidentical Bone Marrow Transplantation for AML
|
5K01CA188151-03
|
$169,020
|
OROZCO, JOHNNIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|